Literature DB >> 5572111

Quantitative determination of drug bioavailability and biokinetic behavior from pharmacological data for ophthalmic and oral administrations of a mydriatic drug.

V F Smolen.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 5572111     DOI： 10.1002/jps.2600600304

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  10 in total

1.  Pharmacokinetics of theophylline in relation to increased pain sensitivity in the rat.

Authors:  L K Paalzow
Journal:  J Pharmacokinet Biopharm       Date:  1975-02

Review 2.  Pattern Recognition in Pharmacodynamic Data Analysis.

Authors:  Johan Gabrielsson; Stephan Hjorth
Journal:  AAPS J       Date:  2015-11-05       Impact factor: 4.009

3.  Dose-effect curves and relative biophasic drug levels: elucidation of these concepts and the illustration of their use for the determination of bioavailability, rate of absorption, and time course of pharmacological response.

Authors:  W A Weigand; A K Jhawar
Journal:  J Pharmacokinet Biopharm       Date:  1976-02

4.  Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.

Authors:  V F Smolen
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

5.  COMPT, a time-sharing program for nonlinear regression analysis of compartmental models of drug distribution.

Authors:  M Pfeffer
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

6.  Effect of route of administration on drug disposition.

Authors:  S Riegelman; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

7.  Kinetic-pharmacodynamic model for drugs with non-linear elimination: Parameterisation matters.

Authors:  Qing Xi Ooi; Chihiro Hasegawa; Stephen B Duffull; Daniel F B Wright
Journal:  Br J Clin Pharmacol       Date:  2020-01-10       Impact factor: 4.335

8.  Turnover modeling of non-esterified fatty acids in rats after multiple intravenous infusions of nicotinic acid.

Authors:  Christine Isaksson; Johan Gabrielsson; Kristina Wallenius; Lambertus A Peletier; Helena Toreson
Journal:  Dose Response       Date:  2009-04-08       Impact factor: 2.658

Review 9.  Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis.

Authors:  Serge C L M Cremers; Goonaseelan Pillai; Socrates E Papapoulos
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

10.  Impact of mathematical pharmacology on practice and theory: four case studies.

Authors:  Lambertus A Peletier; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-09-07       Impact factor: 2.745
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.